ALDX Shares Outstanding History
Below is a table of the ALDX shares outstanding history going back to 5/2/2014:

Date ALDX Shares Outstanding
5/2/20145.17M
6/10/20145.57M
8/6/20145.57M
11/11/20145.57M
3/15/20156.89M
5/13/20159.59M
8/14/20159.71M
11/13/20159.71M
5/9/20169.71M
8/10/201612.47M
11/14/201612.58M
3/30/201715.13M
5/15/201715.13M
8/7/201715.15M
11/9/201719.12M
3/29/201819.66M
5/18/201820.11M
8/9/201820.97M
11/14/201826.24M
3/8/201927.40M
5/10/201927.49M
8/9/201927.58M
11/7/201927.95M
3/10/202029.66M
5/5/202029.79M
8/4/202038.63M
11/3/202038.82M
3/8/202147.25M
5/4/202157.63M
8/3/202157.86M
10/26/202158.09M
3/15/202258.10M
5/2/202258.30M
8/2/202258.32M
11/8/202258.56M

Also see: ALDX Market Cap History
ALDX YTD Return
ALDX Historical Shares Outstanding:
+32.93% CAGR
ALDX Historical Shares Outstanding: +32.93% CAGR

Mouse over chart for data details
5/2/2014 ...11/8/2022
Aldeyra Therapeutics is a biotechnology company focused on discovering and developing therapies designed to treat immune-mediated diseases. Co.'s primary product candidate, reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. Co. has additional product candidates in development for autoimmune diseases and other immune-mediated disease, as well as for proliferative vitreoretinopathy (PVR) and other retinal diseases. Co. has rights to ADX-2191, a vitreous-compatible methotrexate formulation for intraocular injection, for the prevention of PVR, a retinal disease, and primary vitreoretinal lymphoma, a rare cancer. We show 35 historical shares outstanding datapoints in our coverage of ALDX's shares outstanding history.

Understanding the changing numbers of ALDX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ALDX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ALDX by allowing them to research ALDX shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree ALDX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Aldeyra Therapeutics (ALDX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

ALEC Shares Outstanding History
ALGN Shares Outstanding History
ALGS Shares Outstanding History
ALHC Shares Outstanding History
ALIM Shares Outstanding History
ALKS Shares Outstanding History
ALLK Shares Outstanding History
ALLO Shares Outstanding History
ALNA Shares Outstanding History
ALNY Shares Outstanding History
More Healthcare companies »

 

ALDX Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2022, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.